Jesua Law, DO
Orthopaedic Surgery · Modesto, CANPI 1487090049
Payments from drug & device makers
Across 59 payments — averaging $192.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Maxx Orthopedics, Inc.$3K
- Zimmer Biomet$1K
- Sequoia Surgical, Inc.$1K
- Ortho Development Corporation$1K
- Total Joint Orthopedics, Inc.$302
- plus $524 from 6 others
Across 1 payment — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Maxx Orthopedics, Inc.$3K
What the payments were for
- Travel & lodging$5,40548%
- Food & beverage$4,76142%
- Education$1,20011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 24 | $4,195 |
| Maxx Orthopedics, Inc. | 8 | $2,609 |
| Zimmer Biomet | 8 | $1,408 |
| Sequoia Surgical, Inc. | 1 | $1,200 |
| Ortho Development Corporation | 3 | $1,127 |
| Total Joint Orthopedics, Inc. | 6 | $302 |
| Aesculap Implant Systems, LLC | 2 | $191 |
| Davol Inc. | 1 | $120 |
| Johnson & Johnson(2 entities) | 2 | $111 |
| Solventum Corporation | 2 | $41 |
| Smith+Nephew | 1 | $37 |
| Omnilife Science, Inc | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRO$2,325
- MAKO$947
- Persona Revision$919
- BKS TriMax$580
- Balanced Knee Revision System$580
- Arcos$180
- AXSOS$175
- ENDURO AS$155
- Balanced Knee System$128
- Balance Knee Revision System$128
- VARIAX$125
- ARISTA AH FLEXITIP$120
- Persona$119
- GAMMA$114
- HOFFMANN$108
How this compares
$11,366 in reported general payments places this provider in the 70th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 302 | $5,027 |
| Meloxicam | 763 | $2,330 |
| Celecoxib | 86 | $1,851 |
| Oxycodone Hcl | 142 | $687 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $511 |
| Ondansetron Hcl | 76 | $425 |
| Cyclobenzaprine Hcl | 22 | $402 |
| Ibuprofen | 19 | $273 |
| Naproxen | 21 | $169 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $130 |
| Cephalexin | 76 | $110 |
| Tramadol Hcl | 22 | $100 |
| Gabapentin | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Modesto
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.